Benitec Biopharma Inc.BNTCNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+73.5%
5Y CAGR+36.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+73.5%/yr
vs -2.6%/yr prior
5Y CAGR
+36.9%/yr
Recent acceleration
Acceleration
+76.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.8x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$31.32M+33.7%
2025$23.43M+252.6%
2024$6.65M+10.7%
2023$6.00M-9.7%
2022$6.65M+2.1%
2021$6.51M+17.0%
2020$5.57M-16.4%
2019$6.66M+3.9%
2018$6.41M-8.3%
2017$6.99M-